Sign in
4

Changes in Ownership

SAB Biotherapeutics, Inc. Filed Acc 0000950170-23-066901

Executive Chairman bought 11,000 shares at $0.89 ($9,842)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Reich Samuel J Executive Chairman 2023-11-29 Purchase +11,000 $0.89 $9,842 219,001 D
Open-market purchases · 11,000 sh · avg $0.89 · $9,842
Loading xslF345X05/ownership.xml…